Zai Lab Announces Participation in September Investor Conferences
August 29 2023 - 7:38AM
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that
members of the company’s senior management team will participate in
the following investor conferences in September 2023:
Citi's 18th Annual BioPharma
ConferencePanel Discussion: Wednesday, September 6th at
10:30 a.m. ETLocation: Boston
2023 Cantor Global Healthcare
ConferenceFireside Chat: Wednesday, September 27th at 8:00
a.m. ETLocation: New York
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative,
research-based, commercial-stage biopharmaceutical company based in
China and the United States. We are focused on discovering,
developing, and commercializing innovative products that address
medical conditions with significant unmet needs in the areas of
oncology, autoimmune disorders, infectious diseases, and
neuroscience. Our goal is to leverage our competencies and
resources to positively impact human health in China and
worldwide.
For additional information about Zai Lab, please visit
www.zailaboratory.com or follow us at
www.twitter.com/ZaiLab_Global.
For more information, please contact:
Investor Relations:Christine Chiou / Lina
Zhang+1 (917) 886-6929 / +86 136 8257
6943christine.chiou1@zailaboratory.com /
lina.zhang@zailaboratory.com
Media:Shaun Maccoun / Xiaoyu Chen+1 (415)
317-7255 / +86 185 0015 5011shaun.maccoun@zailaboratory.com /
xiaoyu.chen@zailaboratory.com
Zai Lab Limited
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From Apr 2024 to May 2024
Zai Lab (NASDAQ:ZLAB)
Historical Stock Chart
From May 2023 to May 2024